Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease affecting people who have suffered repeated concussions and traumatic brain injuries (TBI). CTE was first described in 1928 by Dr. Harrison…

Many years ago, I was playing hide and seek with my cousins at my grandparent’s house. I was “it” and couldn’t seem to find one of my cousins anywhere. After…

Azenta Life Sciences, formerly known as GENEWIZ, has been serving the academic and biopharma markets with its comprehensive next-generation sequencing services (NGS) since 1999. Their extensive website of Services makes…

What is Multiple Sclerosis? In 1868, a German physician Leopold Ordenstein and his mentor Jean-Martin Charcot, published a work that fundamentally changed our understanding of the disease Multiple Sclerosis1. For…

In a highly interconnected world, clear communication and information across the globe are critical. The same is true at the tissue and cellular levels. Cells communicate through chemical signals such…

The 40 Under 40 program, now in its 23rd year, includes professionals from life sciences, health care, aerospace, tech, food services, and nonprofits, among other sectors. The honorees were selected…

“A rose started off a bud, a bird started off an egg, and a forest started off a seed.” (Matshona Dhliwayo, author and philosopher). It may seem odd, but the…

Spatial Transcriptomics is used to determine subcellular localization of mRNA molecules. NanoString explains how this data enhances research.

Established in 2007, the Nature Methods’ “Method of Year” feature has covered the most revolutionary methodological developments in life science research.   Starting in 2007, the Method of Year winner was,…

During her post doc years, Trieu My Van explored the effects of immuno check point blockade in melanoma patients, comparing samples from metastatic uveal and cutaneous melanoma tissues at the…

Immuno-oncology, also known as cancer immunotherapy, is a treatment that harnesses the power of our immune system to fight cancer. The selective efficacy of immunotherapies continues to provide impetus for…